Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS-Reference-Cited by-同舟云学术

Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS

Published:2017-07-07 Issue:11 Volume:19 Page:1587-1593
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Engel Samuel S.¹^ORCID,Suryawanshi Shailaja¹,Stevens Susanna R.²,Josse Robert G.³,Cornel Jan H.⁴⁵,Jakuboniene Neli⁶,Riefflin Axel⁷,Tankova Tsvetalina⁸,Wainstein Julio⁹,Peterson Eric D.²,Holman Rury R.¹⁰,

Affiliation:

1. Merck & Co., Inc.; Kenilworth New Jersey

2. Duke Clinical Research Institute; Duke University School of Medicine; Durham North Carolina

3. St. Michael's Hospital; University of Toronto; Toronto Canada

4. Department of Cardiology; Noordwest Ziekenhuisgroep; Alkmaar the Netherlands

5. Working group on Cardiovascular Research the Netherlands (WCN); Utrecht the Netherlands

6. Department of Endocrinology; Lithuanian University of Health Sciences; Kaunas Lithuania

7. GMP Husby; Husby Germany

8. Clinical Center of Endocrinology; Medical University; Sofia Bulgaria

9. Wolfson Medical Center, Sackler Faculty of Medicine; Tel-Aviv University; Tel Aviv, Israel

10. Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism; University of Oxford; Oxford UK

Funder

Merck & Co., Inc.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12983/fullpdf

Reference13 articles.

1. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective;Parving;Kidney Int,2006

2. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus;Iglay;Curr Med Res Opin,2016

3. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease;Thomas;Nat Rev Nephrol,2016

4. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

5. Metformin in patients with type 2 diabetes and kidney disease: a systematic review;Inzucchi;JAMA,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy;Diabetologia;2023-08-19

2. The Effects of Non-Insulin Anti-Diabetic Medications on the Diabetic Microvascular Complications: A Systemic Review and Meta-Analysis of Randomized Clinical Trials;2023

3. Prescription of DPP4 inhibitors: indication and effect on glycosylated hemoglobin in a primary care institution of Colombia;Salud UIS;2022-01-02

4. Carbohydrate metabolism in chronic renal disease;Nutritional Management of Renal Disease;2022

5. High‐throughput bioanalysis of sitagliptin in plasma using direct analysis in real time mass spectrometry and its application in the pharmacokinetic study thereof;Journal of Separation Science;2021-11-10